Yasmin and Cefzil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Yasmin (drospirenone; ethinyl estradiol) and Cefzil (cefprozil). Common drug interactions include cholecystitis acute among females.

The phase IV clinical study analyzes what interactions people have when they take Yasmin and Cefzil. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

What is Cefzil?

Cefzil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,106 Cefzil users. Check the latest studies of Cefzil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

15 people who take Yasmin and Cefzil together, and have interactions are studied.

What are the common drug interactions of Yasmin and Cefzil, by gender? *:

female:

Cholecystitis acute (rapid infection of gallbladder)
Abdominal pain
Injury
Abortion (termination of pregnancy)
Anxiety
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dyspnoea (difficult or laboured respiration)
Embolism venous (embolus may pass into the arterial system)
Emotional distress
General physical health deterioration (weak health status)

male:

n/a

What are the common drug interactions of Yasmin and Cefzil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Anxiety
Dyspnoea (difficult or laboured respiration)
Emotional distress
General physical health deterioration (weak health status)
Injury
Pain
Pulmonary embolism (blockage of the main artery of the lung)

20-29:

Upper respiratory tract infection
Chest discomfort
Chest pain
Pain
Abortion (termination of pregnancy)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Injury
Cholangitis (infection of the bile duct)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Oropharyngeal pain

30-39:

Arthralgia (joint pain)
Fluid retention (an abnormal accumulation of fluid in the blood)
Pruritus (severe itching of the skin)

40-49:

n/a

50-59:

Embolism venous (embolus may pass into the arterial system)
Pulmonary embolism (blockage of the main artery of the lung)

60+:

n/a

What are the existing conditions these people have? *

Pain: 8 people, 53.33%
Upper Respiratory Tract Infection: 5 people, 33.33%
Premenstrual Syndrome: 5 people, 33.33%
Menstrual Disorder (disease of menstrual cycle): 5 people, 33.33%
Nausea (feeling of having an urge to vomit): 2 people, 13.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and Cefzil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously